Feedback / Questions
DOC1021 - Diakonos Research
https://www.businesswire.com/news/home/20240102095438/en/Diakonos-Oncology-Completes-Phase-1-Glioblastoma-Trial-Recruitment-Receives-FDA-Orphan-Drug-Designation
Jan 2, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next